Does continuous-cycle usage of Lo Loestrin Fe lead to higher rates of amenorrhea and spotting compared to traditional 21-day regimens in active female athletes?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Does continuous-cycle usage of Lo Loestrin Fe lead to higher rates of amenorrhea and spotting compared to traditional 21-day regimens in active female athletes?
1 real search · 1 real-search pass
Lo Loestrin Fe continuous use amenorrhea spotting clinical trial bleeding rates prescribing information athletes extended continuous combined oral contraceptiveGoogle ↗
OBSERVEDConsequence
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
ChatGPT real searches (1)
Classes come from the query-classifier (a local Laya model). 1 of 1 calls are low-confidence (under 50%) — hover a query in the table to see its confidence.
Searches and sources
ChatGPT1 real searches · gpt-6
Lo Loestrin Fe continuous use amenorrhea spotting clinical trial bleeding rates prescribing information athletes extended continuous combined oral contraceptive Google ↗
- These highlights do not include all the information needed to use Lo Loestrin Fe safely and effectively. See full prescribing information for Lo Loestrin Fe. Lo Loestrin ® Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) Initial U.S. Approval: 1968 · dailymed.nlm.nih.gov
- DailyMed - These highlights do not include all the information needed to use Lo Loestrin Fe safely and effectively. See full prescribing information for Lo Loestrin Fe. Lo Loestrin ® Fe (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets and ferrous fumarate tablets) Initial U.S. Approval: 1968 · dailymed.nlm.nih.gov
- Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial · pubmed.ncbi.nlm.nih.gov
- General Approaches to Medical Management of Menstrual Suppression · acog.org
- U.S. Selected Practice Recommendations for Contraceptive Use, 2024 · doi.org
- Appendix E: Management of Bleeding Irregularities While Using Contraception | Contraception · cdc.gov
- Effectiveness, safety and acceptability of continuous or extended-cycle use of combined oral contraceptives (COCs): a systematic review and meta-analysis · srh.bmj.com
- Hormonal Contraceptive Use, Menstrual Dysfunctions, and Self-Reported Side Effects in Elite Athletes in Denmark · pubmed.ncbi.nlm.nih.gov
- Contraception Choice for Female Endurance Athletes: What’s Sport Got to Do With It? A Cross-Sectional Survey · pmc.ncbi.nlm.nih.gov
- The Women’s Tennis Association (WTA) Multidisciplinary Education and Treatment Protocol for the Female Athlete Triad (1996–2022) · pmc.ncbi.nlm.nih.gov
Queries
1 queries · click a column to sort